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ABSTRACT
Background: exercise reduces medication usage in hypertensive people. However, different domains
of physical activity (PA) have not been studied in order to analyze their relationship with the use of
multiple medications, known as polypharmacy. Purpose: To examine the association between PA in
different domains (leisure-time, locomotion and occupational) and polypharmacy in hypertensive pa-
tients. Methods: This is a cross-sectional study carried out with 190 hypertensive patients. Polyphar-
macy was defined as simultaneous use of three or more drugs. The PA domains were the independent
variables: Locomotion PA (LPA), Leisure Time PA (LTPA) and Occupational PA (OPA). The multiple logistic
regression was performed to analyze the associations. The Mann Whitney test determined whether
medications usage differ according to each domain of PA. Results: The total number of drugs used
ranged from 0 to 7, which represents an average of 2.35 (±1.6) drugs per person. Scores of LTPA (OR:
3.25; CI95%:1.61-6.54) and LPA (OR: 2.15; CI95%:1.09-4.25) were inversely associated with polyp-
harmacy in hypertensive patients, in the multiple logistic regression analysis (controlled by BMI, chronic
diseases, smoking, alcohol consumption and skin color). Conclusions: lower PA in leisure time and
locomotion were associated with polypharmacy in hypertensive people.
Keywords: Hypertension. Physical Activity. Polypharmacy.
RESUMO
Introdução: o exercício reduz o uso de medicamentos em indivíduos hipertensos. Contudo, diferentes
domínios de atividade física (AF) não têm sido estudados no intuito de analisar suas relações com o uso
de múltiplos medicamentos, conhecido como polifarmácia. Objetivo: analisar a associação entre AF em
diferentes domínios (tempo livre, locomoção e ocupação) e polifarmácia em indivíduos hipertensos.
Métodos: trata-se de um estudo transversal realizado com 190 hipertensos. Polifarmácia foi definida
como o uso simultâneo de três ou mais drogas. As variáveis independentes foram os domínios de AF:
Locomoção (AFL); Tempo Livre (AFTL) e Ocupacional (AFO). A regressão logística múltipla foi emprega-
da para analisar as associações. O teste de Mann Whitney foi empregado para comparar se a média de
medicamentos usados diferia entre domínios de AF. Resultados: o número total de drogas usadas
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Sao Paulo State of Brazil. It was estimated that ap-
proximately 835 hypertensive patients were attended
by these Health Centers in the study occasion. All
hypertensive were aged over 40 years and had been
diagnosed with hypertension for at least 12 months.
All hypertensive patients UBS’s were invited to par-
ticipate. However, according to sample size calcula-
tion (according to hypertension prevalence in Bauru),
the age criteria and time of diagnosis, the same re-
searcher interviewed a total of 190 subjects.
The subjects were informed about the assess-
ment procedures and conditions for participation in
the research. Subsequently, they signed a consent
form approved by the Research Ethics Committee
of the Faculty of Science and Technology, São Paulo
State University - UNESP – Presidente Prudente
Campus (No. 322-08), authorizing the use of infor-
mation for scientific purposes and ensuring their
confidentiality.
Polypharmacy
The number of medications was verified in
the clinical record of each patient. All prescribed
medications were computed, regardless of their
pharmacological action, specific clinical treatment
intended or diseases. There is no consensus for
polyoharmacy in literature,17 it has been shown as
varying from two or more drugs18 to nine or more
drugs.19 In this study polypharmacy was defined as
the concomitant use of three or more drugs. This
cutoff is commonly used in national20 and interna-
tional studies.21,22
Domains of Physical Activity
Physical activity was self-reported by inter-
view using Baecke questionnaire.23 This method has
been nationally validated in male adults.24,25 The
questionnaire categorizes the daily physical activ-
ity into three domains: OPA, LTPA and LPA. Scores
calculation have been described before.23
There is no established criterion in the litera-
ture for the PAL classification based on Baecke score.
Background
The prevalence of hypertension is estimated
at between 20 and 40% in adults from developing
and developed nations. 1,2,3 The high risk of cardio-
vascular mortality in hypertensive patients 4 makes
blood pressure control important for long-term sur-
vival on this population. Thus, the simultaneous
prescription of different drugs (diuretics, adrener-
gic inhibitors, vasodilators, and beta blockers) is
common in hypertensive patients, which character-
izes the use of antihypertensive drugs as a com-
mon behavior.5 Nevertheless, the use of more than
one drug and their interactions have adverse ef-
fects on health, increase hospitalization and emer-
gency care,6,7 and hence, an increased burden on
health care costs.8
Adherence to a drug-free approach to blood
pressure control has been recommended, which
consists of changes in lifestyle, including exercis-
ing, diet control, and alcohol and cigarette restric-
tion.2 In addition to obesity, indicated by a BMI
≥30kg/m2, 9 low physical activity level (PAL) is also
associated with hypertension development,10,11 on
the other hand aerobic exercises are effective in
reducing both blood pressure12,13,14 and medication
intake.15,16 Despite this, the effects of everyday ac-
tivities such as occupational (OPA), locomotion (LPA)
and leisure-time (LTPA) on medications intake and
polypharmacy are little known.
Thus, this study aimed to analyze, in a sample
of hypertensive patients, the association between
levels of occupational, leisure time and locomotion




This study was conducted in two health cen-
ters located in the southwestern region of Bauru,
variou de 0 a 7, com média de 2.35 (±1.6) por pessoa. Escores de AFTL (OR: 3.25; IC95%: 1.61-6.54)
e AFL (OR: 2.15; IC95%: 1.09-4.25) foram inversamente associadas à polifarmácia em hipertensos
(controlado por IMC, número de doenças crônicas, fumo, consumo de álcool e cor da pele). Conclusão:
menor AF no tempo livre e de locomoção foi associada à polifarmácia em indivíduos hipertensos.
Palavras-chave: Hipertensão. Atividade Física. Polifármacos.
.
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To enable binary logistic regression analysis, the
participants were divided into two groups: partici-
pants who scored above the median score (refer-
ence) and patients who scored below the median
score.
Explanatory Variables (control)
Number of diseases such as cardiovascular
and type 2 diabetes, and presence or absence of
smoking and alcohol consumption, educational level
(categorized as < eight years of education and
≥ eight years of education) and skin color (catego-
rized as white or other) were self-reported in a ques-
tionnaire. Body mass index (BMI - kg/m²) was cal-
culated using the values of body weight and height,
both measured according to Lohman’s protocol.24
After calculating the BMI, patients were categorized
into two groups: i) BMI <30 kg/m²; and, ii) BMI ≥
30 kg/m².25
Statistical Analysis
For the univariate (chi-squared test) and mul-
tiple analysis, the dependent variable was defined
as polypharmacy and the independent variables were
age, smoking, BMI, type 2 diabetes, number of dis-
eases, gender, alcohol consumption, education and
ethnicity. All variables with a p value < 0.20 in the
univariate analysis were selected for the multiple
logistic regression model (expressed as odds ratios
[OR] and 95% confidence intervals [95%CI]). Fol-
lowing the forward stepwise method, variables that
remained significant (p < 0.05) or which adjusted the
Odds Ratio (OR) by at least 10% were kept in the
model. Kruskal- Wallis and Mann Whitney tests com-
pared medication means according to the PAL in each
domain due to the lack of normality in the dataset.
Statistical significance for associations was consid-
ered when p < 0.05 and all analyzes were performed
using SPSS 20.0 for Windows.
Results
Description of the sample
The mean age of the 130 women and 60 men
was 63 (11) years. All dependent variables accord-
ing to categorization, and their association with
polypharmacy are presented in Table 1. The num-
ber of diseases and diabetes were the variables as-
sociated with polypharmacy in univariate analysis
(p < 0.05). Among the physical activity domains,
only LTPA was associated with polypharmacy (p =
0.036).
Physical activity and drugs
The total number of medications use ranged
from 0 to 7 and 38% of patients reported at least
three drugs on their medical prescription. The total
number of drugs prescribed for the 190 patients
were 446, which represents an average of 2.35 (1.6)
per person. The classes of drugs were not docu-
mented according to their pharmacological action,
however the most prevalent health problems ob-
served in the sample were: hypercholesterolemia
(42%), type 2 diabetes (23%), arthritis (20%), car-
diac arrhythmia and heart attack event (12% each)
and osteoporosis (9%). There was no difference
between the sexes for drugs usage (p> 0.05).
The final logistic regression model of the risk
of polypharmacy adjusted by the number of dis-
eases and education level is presented graphics on
Figure 1. LTPA (OR= 3.25; IC95%= 1.61 – 6.54)
and LPA were associated (OR= 2.15; IC95%= 1.09
– 4.25)) with polypharmacy compared to groups
with lower PAL in these domains (p <0.05). Type 2
diabetes was associated with polypharmacy (OR=
3.79; IC95%= 1.71 – 8.38) in this sample.
Figure 2 demonstrates the comparison be-
tween quartiles of LTPA for drugs use (mean), where
lower medication use was observed with higher PA
scores (i.e. 4th quartile) (p = 0.02). The differences
occurred between the 1st and 3rd quartiles (p =
0.02). Between the 2nd and 3rd quartiles (p = 0.01)
and between the 2nd and 4th quartiles (p = 0.04),
always with the lowest means observed for the in-
tervals with the higher scores. For the other do-
mains studied no statistically significant differences
were observed.
Discussion
The present study examined the association
between different PA domains and polypharmacy in
hypertensive patients. The lower PA score in leisure
time and locomotion were inversely associated with
polypharmacy. The average of drugs use was higher
among individuals with lower PA scores in leisure
time.
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Table 1. Distribution of the sample according to the study variables and number of drugs and association
with polypharmacy (≥ 3 drugs)
Drugs
≤ 2 ≥ 3
n (%) n (%)
Variables 117 (61.6) 73 (38.4) OR CI95% P
Age
< 60 years old 47 (64.4) 26 (35.6) 1.00
≥ 60 years old 70 (59.8) 47 (40.2) 1.21 066 – 2.22 0.53
Smoke
No 11 (61.1) 07 (38.9) 1.00
Yes 106 (61.6) 66 (38.4) 1.02 0.38- 2.77 0.97
Sex
Man 80 (61.5) 50 (38.5) 1.00
Woman 37(61.7) 23 (38.3) 0.99 0.53 – 1.87 0.98
BMI
< 30 kg/ m² 28 (70.0) 12 (30.0) 1.00
≥ 30 kg/ m² 89 (59.3) 61 (40.7) 1.60 0.76 – 3.39 0.22
Education
≥ 8 years 25 (53.2) 22 (46.8) 1.00
< 8 years 92 (6.3) 51 (35.7) 0.63 0.32 – 1.23 0.17
Ethnic group
White 70 (59.8) 47 (40.2) 1.00
Others 47 (64.4) 26 (35.6) 0.82 0.45 – 1.51 0.53
Alcohol
No 104 (60.5) 68 (39.5) 1.00
Yes 13 (72.2) 05 (27.8) 0.59 0.20 – 1.73 0.33
Diabetes
No 100 (68.5) 46 (31.5) 1.00
Yes 17 (38.6) 27 (61.4) 3.45 1.71 – 6.95 0.001*
Number of diseases
≤ 2 94 (66.7) 47 (33.3) 1.00
≥ 3 23 (46.7) 26 (53.1) 2.26 1.17 – 4.38 0.01*
Physical Activity Score
OPA
Higher 68 (66.7) 34 (33.3) 1,00
Lower 49 (55.7) 39 (44.3) 1.59 0.88 – 2.87 0.12
LTPA
Higher 68 (68.7) 31 (31.3) 1,00
Lower 49 (58.3) 42 (46.2) 1.88 1.04 – 2.40 0.04*
LPA
Higher 54 (67.5) 26 (32.5) 1,00
Lower 63 (57.3) 47 (42.7) 1.55 0.85 – 2.83 0.15
Note: BMI – body mass index; OPA – occupational physical activity; LTPA – leisure-time physical activity; LPA – locomotion physical
activity. *statistical significance for univariate logistic regression
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Figure 1. Means of drug use between LTPA quartiles. (Mann Whitney analysis) LTPA – leisure-time physical activity
Figure 2. Final model of logistic regression to association of physical activity level in each domain (scores) and drugs use. (Logistic
Regression). Odds Ratio values and interval of confidence (IC95%).
is common in older groups16 due to the higher preva-
lence of chronic diseases. Regarding this analysis,
it is noteworthy that medications computed in this
study were those prescribed by the doctor, there-
fore other drugs, self-administered by patients were
not known, i.e., the number of drugs could be higher
when considering that the participants could have
self-medicated ,30 which is common in the elderly.
The drugs use were slightly lower than other
Brazilian studies, researchers found an average of
3,2 in a study in Porto Alegre city26 and 3,6 in São
Paulo city.27 In United States, there are reports
showing that elderly people use between 2,7 and
4,2 drugs,28 in Sweden the averages were 1,6 for
subjects between 50 and 64 years old and 3,2 for
those between 65 and 75 years old.29 Polypharmacy
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In relation to the presence of type 2 diabe-
tes, Carvalho et al. founded the risk of polyphar-
macy four times higher among elderly who self-re-
ported this disease.27 It is important to verify that
all the above diseases, such as type 2 diabetes, have
sedentary lifestyle as a risk factor and can there-
fore be controlled by the adoption of regular physi-
cal activity31 which thereby reflects in a decreased
of drug intake, as previously described by several
studies.32-35
In addition, exercise causes reduction in fat
percentage and body weight, components which are
directly associated with the greatest need for inter-
vention by drug therapy in hypertensive patients.
36,37 Leisure-time activities such as walking or gar-
dening may have beneficial cardiovascular effects,
even if they do not qualify as physical training.39,40
Thus, it is expected that more physically active pa-
tients have better health outcomes and show a lower
prevalence of polypharmacy. The literature has
shown that exercise plays an important role in con-
trolling chronic disease parameters, such as blood
pressure.41 Selmer et al. showed that the preva-
lence of hypertensive patients, without cardiovas-
cular diseases, receiving drugs decrease 3%, 5,9%
and 11,4% in agreement with a decrease of 1, 2
and 4mmHg in blood pressure, respectively.42
However, Fulton and Allen, points out the
absence of studies which evaluated types of inter-
vention that could be applied to reduce polyphar-
macy.43 The authors mention that there is no evi-
dence in the literature of effective measures for
challenging the exacerbating prescription of medi-
cations, in addition to the issue of self-medication.
It has been shown that elderly women who
walk 8,500 steps per day consume fewer medica-
tions than those who walk 6000 steps;44 lower num-
ber of steps compared to those 10,000 found to be
associated with maintenance of health and weight
control in healthy adults.45 The study conducted in
southern Brazil by Bertoldi et al., showed that in-
crease minutes of moderate and vigorous PA spent
per week were associated with less medication use;
in adjusted analysis, sedentary (0 minutes per week)
individuals showed 23% higher medicine use in com-
parison to very active (>1000 minutes per week).46
Using the recommended 150 minutes per week of
moderate physical activity as a criterion for the same
analyzes, inverse association between PAL and medi-
cation use was founded.39
Analyzing the association between physical
activity level and drugs use, Bardel et al. showed
that 40% of women aged between 35 and 65 years-
old using drugs, reported lower LTPA (p <0.05) and
OPA (p <0.01). 47 Our results showed no associa-
tion between OPA and drugs use, contradictory to
the 80% greater chance of polypharmacy (95% CI
1.1 to 2.7) in individuals who reported exercising
at work, compared to individuals retired or unem-
ployed.27
Our study had a cross-sectional approach,
which may limit the interpretation of the results with
regard to the causal relationship between PA and
drug consumption. Another limitation is the esti-
mate of PA through the use of a questionnaire, which
can differ from more accurate methods and overes-
timate PAL. However, the method used in this re-
search was validated for the Brazilian population
and had the advantage of being low cost and en-
abling easy data collection.
In summary, physical activity in leisure time
and locomotion were inversely associated with
polypharmacy in hypertensive individuals. The treat-
ment of patients with chronic diseases should be as
effective as possible, as they will continue to use
mechanisms of disease control throughout their
lives, thus, physical activity should be incorporated
into other methods adopted by patients.
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